PatientsVisitorsLocations & ServicesAbout the RegionJoin Our TeamPhysicians
Find:  Locations | Services
Pathology and Laboratory Medicine HomeTest and Services CatalogueTransfusion Medicine Product CataloguePolicy and ProcedureJob AidsSpecimen Collection and TransportRequisitionsAntibiogramsGenetic Testing and Molecular GeneticsMicrobiology EssentialsTransfusion EssentialsReference RangesLaboratory SuppliesAcute Care SCM GuidelinesContact InformationPhysician Access to Patient ResultsNew Clinic or Provider Information Changes
Pathology and Laboratory Medicine
Product Catalogue

​Coagulation Factor VII a Concentrate (Recombinant)

Transfusion Medicine

​Alternate Product Names
  • ​Recombinant Factor VIIa Concentrate
  • Factor VIIa
  • VIIa
  • NiaStase
​Indications
  • ​Prevention and treatment of bleeding episodes in patients with:
    • Congenital factor VIII deficiency (Hemophilia A) or congenital factor IX deficiency (Hemophilia B) with factor inhibitors
    • Acquired factor VIII or factor IX deficiency with factor inhibitors
    • Glanzmann’s thrombasthenia with clinical refractoriness and/or platelet-specific antibodies, or where platelets are not immediately available
​Resource Information

​Product Monographs:

Product Information:

National Recommendations on Use in Massive Bleeding:
Size/Volume Available
  • Niastase RT® (Activated Recombinant Factor VIIa)
    • Volumes Available: 1 mg, 2 mg, 5 mg
  • Products not listed may be available through Canadian Blood Services by contacting Transfusion Medicine or your site laboratory
Availability
​RUH​SCH​SPH​Rural
​Yes​NoYes​Contact your site laboratory
  • ​SCH and SPH requests will be transported from RUH as requests are received
Pretransfusion Testing Requirements
  • ​None required
Forms Required

​Saskatoon:

Rural:

  • Contact your site laboratory
Home infusion program:
Ordering
  • Specify dosage required
  • Off-label use of this product is strongly discouraged. Requests for anyone other than bleeding disorders patients must be discussed with and approved by the on-call Transfusion Medicine Physician
​Notes
​Administration
  • ​Refer to product monograph
  • Does not contains human protein
  • Consent for off-label use of this product must be documented in the patient chart by the ordering physician

 

If you choose to print this information, it is valid only on date of print.

Laboratory Controlled Document LSM-54 v5

Last Modified: Tuesday, April 24, 2018 |
Questions or feedback about this page?